Skip to main content
European Commission logo
European Health and Digital Executive Agency (HaDEA)

Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases

  • Call for proposals
  • Open

Details

Status
Open
Reference
HORIZON-HLTH-2027-02-TOOL-01-two-stage
Publication date
7 October 2026 in Funding and Tenders Portal
Opening date
Deadline model
Two-stage
Deadline dates
17 Feb 2027, 17:00 / 16 Sep 2027, 17:00 (CEST)
Funding programme
Programme Sector
  • Health
Programme
  • Horizon Europe
  • Horizon Europe Cluster 1: Health
Tags
  • HealthUnion
  • Medical research
  • Scientific research

Description

Biomarkers are invaluable tools for improving patient outcomes, guiding treatment decisions, accelerating personalised medicine, more effective clinical research and the development of better medicines.

However, despite the scientific discoveries of many clinically relevant biomarkers, estimated on the scale of tens of thousands, only a few biomarkers have been implemented in clinical practice. 

Therefore, the topic focuses on the clinical development of predictive biomarkers of disease progression and treatment response for chronic non-communicable diseases (excluding cancer) by using established AI methodologies able to combine data of clinically used and candidate biomarkers, with available data from relevant clinical studies, longitudinal and Real-World Data (RWD)[2]. This topic is expected to support collaborative projects paving the way for future innovations in personalised medicine and enabling more timely and effective therapeutic interventions.

Read more and apply on the Funding and Tenders Portal.